All marketing authorization holders of medicine are hereby informed that NMRA would not register new products, renew or issue import license of existing external preparations containing combinations of antifungal with potent or very potent steroids.

Combinations of antifungal with mild steroid can be considered for registration. The potency of steroid is considered as per the classification mentioned in the BNF.

(Date: 13 November 2023)